Bixiye
QP44-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Zeposia® (ozanimod)
Taariikhda uu dhaqangalayo Barnaamijka: May 26, 2021
Natiijooyinka Raadinta
Soo bandhiga 2241 - 2250 ee natiijooyinka 4139
Bixiye
2021 June Provider Press
Taariikhda uu dhaqangalayo Barnaamijka: May 25, 2021
Bixiye
QP41-21 Commercial and MHCP Pharmacy Benefit Exclusion for Qutenza®
Taariikhda uu dhaqangalayo Barnaamijka: May 12, 2021
Bixiye
QP42-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Hemophilia Agents
Taariikhda uu dhaqangalayo Barnaamijka: May 12, 2021
Bixiye
QP2-21 Update for New to Market Medical Drugs: Aducanumab, Casimersen, Evinacumab, Idecabtagene Vicleucel, and Pegunigalsidase Alfa
Taariikhda uu dhaqangalayo Barnaamijka: Jan 13, 2021
Bixiye
P29-21 Reimbursement Change for Licensed Professional Clinical Counselors (LPCC)
Taariikhda uu dhaqangalayo Barnaamijka: May 03, 2021